Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery
-10%
portes grátis
Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery
Kesharwani, Prashant
Elsevier - Health Sciences Division
03/2022
532
Mole
Inglês
9780323912150
15 a 20 dias
Descrição não disponível.
PART A Synthesis and characterization of PLGA nanoparticles for drug delivery
1. History, introduction, and properties of PLGA nanoparticles as drug delivery carriers
2. Preparation and characterization of PLGA nanoparticles
3. Drug loading methods and mechanism of drug release from PLGA nanoparticles
4. Biofate and cellular interactions of PLGA nanoparticles
PART B Application of PLGA nanoparticles in drug delivery
5. Targeting strategies using PLGA nanoparticles for efficient drug delivery
6. Current progress in PLGA-based nanoparticles for treatment of cancer diseases
7. PLGA-based nanoparticles for enhanced diagnosis and cancer therapy
8. PLGA-based nanoparticles for the treatment of inflammatory diseases
9. PLGA-based nanoparticles for treatment of cerebral diseases
10. PLGA-based nanoparticles for treatment of cardiovascular diseases
11. PLGA-based nanoparticles for treatment of infectious diseases
12. PLGA-based nanoparticles as regenerative medicine
13. Photodynamic and photothermal therapy using PLGA nanoparticles
14. Gene therapy using PLGA nanoparticles
PART C Recent advances and regulatory aspects in PLGA nanoparticles
15. Hybrid PLGA nanoparticles as advanced drug delivery and theranostic applications
16. Clinical translation of PLGA nanoparticles into the market
17. Biological toxicity and environmental hazards associated with PLGA nanoparticles
18. PLGA nanoparticles: Current uses and emerging trends
1. History, introduction, and properties of PLGA nanoparticles as drug delivery carriers
2. Preparation and characterization of PLGA nanoparticles
3. Drug loading methods and mechanism of drug release from PLGA nanoparticles
4. Biofate and cellular interactions of PLGA nanoparticles
PART B Application of PLGA nanoparticles in drug delivery
5. Targeting strategies using PLGA nanoparticles for efficient drug delivery
6. Current progress in PLGA-based nanoparticles for treatment of cancer diseases
7. PLGA-based nanoparticles for enhanced diagnosis and cancer therapy
8. PLGA-based nanoparticles for the treatment of inflammatory diseases
9. PLGA-based nanoparticles for treatment of cerebral diseases
10. PLGA-based nanoparticles for treatment of cardiovascular diseases
11. PLGA-based nanoparticles for treatment of infectious diseases
12. PLGA-based nanoparticles as regenerative medicine
13. Photodynamic and photothermal therapy using PLGA nanoparticles
14. Gene therapy using PLGA nanoparticles
PART C Recent advances and regulatory aspects in PLGA nanoparticles
15. Hybrid PLGA nanoparticles as advanced drug delivery and theranostic applications
16. Clinical translation of PLGA nanoparticles into the market
17. Biological toxicity and environmental hazards associated with PLGA nanoparticles
18. PLGA nanoparticles: Current uses and emerging trends
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
PLGA; polylactic; glycolic; acid; nanoparticle; nano; drug; delivery; synthesis; characterization; method; carrier; preparation; loading; mechanism; release; biofate; application; targeting; treatment; disease; regenerative; therapy; gene; hybrid; theranostics; toxicity; environment; properties; polymer; nanomedicine; nanotechnology
PART A Synthesis and characterization of PLGA nanoparticles for drug delivery
1. History, introduction, and properties of PLGA nanoparticles as drug delivery carriers
2. Preparation and characterization of PLGA nanoparticles
3. Drug loading methods and mechanism of drug release from PLGA nanoparticles
4. Biofate and cellular interactions of PLGA nanoparticles
PART B Application of PLGA nanoparticles in drug delivery
5. Targeting strategies using PLGA nanoparticles for efficient drug delivery
6. Current progress in PLGA-based nanoparticles for treatment of cancer diseases
7. PLGA-based nanoparticles for enhanced diagnosis and cancer therapy
8. PLGA-based nanoparticles for the treatment of inflammatory diseases
9. PLGA-based nanoparticles for treatment of cerebral diseases
10. PLGA-based nanoparticles for treatment of cardiovascular diseases
11. PLGA-based nanoparticles for treatment of infectious diseases
12. PLGA-based nanoparticles as regenerative medicine
13. Photodynamic and photothermal therapy using PLGA nanoparticles
14. Gene therapy using PLGA nanoparticles
PART C Recent advances and regulatory aspects in PLGA nanoparticles
15. Hybrid PLGA nanoparticles as advanced drug delivery and theranostic applications
16. Clinical translation of PLGA nanoparticles into the market
17. Biological toxicity and environmental hazards associated with PLGA nanoparticles
18. PLGA nanoparticles: Current uses and emerging trends
1. History, introduction, and properties of PLGA nanoparticles as drug delivery carriers
2. Preparation and characterization of PLGA nanoparticles
3. Drug loading methods and mechanism of drug release from PLGA nanoparticles
4. Biofate and cellular interactions of PLGA nanoparticles
PART B Application of PLGA nanoparticles in drug delivery
5. Targeting strategies using PLGA nanoparticles for efficient drug delivery
6. Current progress in PLGA-based nanoparticles for treatment of cancer diseases
7. PLGA-based nanoparticles for enhanced diagnosis and cancer therapy
8. PLGA-based nanoparticles for the treatment of inflammatory diseases
9. PLGA-based nanoparticles for treatment of cerebral diseases
10. PLGA-based nanoparticles for treatment of cardiovascular diseases
11. PLGA-based nanoparticles for treatment of infectious diseases
12. PLGA-based nanoparticles as regenerative medicine
13. Photodynamic and photothermal therapy using PLGA nanoparticles
14. Gene therapy using PLGA nanoparticles
PART C Recent advances and regulatory aspects in PLGA nanoparticles
15. Hybrid PLGA nanoparticles as advanced drug delivery and theranostic applications
16. Clinical translation of PLGA nanoparticles into the market
17. Biological toxicity and environmental hazards associated with PLGA nanoparticles
18. PLGA nanoparticles: Current uses and emerging trends
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
PLGA; polylactic; glycolic; acid; nanoparticle; nano; drug; delivery; synthesis; characterization; method; carrier; preparation; loading; mechanism; release; biofate; application; targeting; treatment; disease; regenerative; therapy; gene; hybrid; theranostics; toxicity; environment; properties; polymer; nanomedicine; nanotechnology